Tim Schlidt

Co-Founder & Partner, Palo Santo

Tim Schildt, co-founder and partner at Palo Santo, brings extensive knowledge investing across life sciences and healthcare services. Tim has held a lifelong passion for understanding and improving treatments for CNS disorders. Having witnessed the immense therapeutic potential of psychedelic medicines, Tim has been one of the most active participants and investors in the emerging industry. Tim believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-founding Palo Santo is to invest in companies and solutions that allow for broad, safe access to those most in need of mental healthcare. Prior to co-founding Palo Santo, he covered the life sciences and healthcare services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill.